OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer
Fang Bai, Peng Zhang, Yi‐Peng Fu, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000169-e000169
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
Sha Li, Jinyi Liu, Xiangjin Zheng, et al.
Cancer Biology and Medicine (2021) Vol. 18, Iss. -
Open Access | Times Cited: 82

Annexin A1 as a Regulator of Immune Response in Cancer
Thaise Gonçalves Araújo, Sara Teixeira Soares Mota, Helen Soares Valença Ferreira, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2245-2245
Open Access | Times Cited: 78

A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers
Hengrui Liu, James P. Dilger, Jun Lin
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108302-108302
Closed Access | Times Cited: 56

Regulatory T cells: Their role in triple‐negative breast cancer progression and metastasis
Rama Rao Malla, Vasudevaraju Padmaraju, Rahul Kumar Vempati, et al.
Cancer (2022) Vol. 128, Iss. 6, pp. 1171-1183
Closed Access | Times Cited: 45

Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer
Pengfei Huang, Xinyue Zhou, Minying Zheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26

Annexin A protein family: Focusing on the occurrence, progression and treatment of cancer
Huhu Zhang, Zhe Zhang, Tingting Guo, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 23

ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers
Zheng-Zheng Yu, Yun-Ya Liu, Wei Zhu, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 3, pp. e006345-e006345
Open Access | Times Cited: 23

CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies
Zhipu Niu, Jingyuan Wu, Qiancheng Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11

Phospholipase A2 Drives Tumorigenesis and Cancer Aggressiveness through Its Interaction with Annexin A1
Lara Vecchi, Thaise Gonçalves Araújo, Fernanda Van Petten de Vasconcelos Azevedo, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1472-1472
Open Access | Times Cited: 55

Annexin Animal Models—From Fundamental Principles to Translational Research
Thomas Grewal, Carles Rentero, Carlos Enrich, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3439-3439
Open Access | Times Cited: 45

Annexin‐A1: The culprit or the solution?
Lauren Kelly, Sarah McGrath, Lewis Rodgers, et al.
Immunology (2022) Vol. 166, Iss. 1, pp. 2-16
Open Access | Times Cited: 37

Effects of lactate on metabolism and differentiation of CD4+T cells
Yuting Zhang, Mu-Lan Xing, Hui-Hua Fang, et al.
Molecular Immunology (2023) Vol. 154, pp. 96-107
Closed Access | Times Cited: 20

A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo
Hussein Al‐Ali, Scott Crichton, Charlene Fabian, et al.
Oncogene (2024) Vol. 43, Iss. 8, pp. 608-614
Open Access | Times Cited: 7

The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance
Kuba Retecki, Milena Seweryn, Agnieszka Graczyk‐Jarzynka, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 6012-6012
Open Access | Times Cited: 39

ANXA1 Promotes Tumor Immune Evasion by Binding PARP1 and Upregulating Stat3-Induced Expression of PD-L1 in Multiple Cancers
Xiao Ding, Ting Zeng, Zhu Wei, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 10, pp. 1367-1383
Closed Access | Times Cited: 15

Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway
Zelin Hou, Fengchun Lu, Jiajing Lin, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 9, pp. e009318-e009318
Open Access | Times Cited: 5

Targeting Annexin A1 as a Druggable Player to Enhance the Anti-Tumor Role of Honokiol in Colon Cancer through Autophagic Pathway
Xi Wang, Gang Shao, Xiangyu Hong, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 70-70
Open Access | Times Cited: 11

The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions
Hanan Qasem, Wael M. El‐Sayed
Clinical and Experimental Medicine (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4

Comprehensive analysis and experiments identified ANXA1 as an unfavorable prognosticator in glioma
Yu Fan, Yanwen Chen, Xingda Run, et al.
Translational Oncology (2025) Vol. 53, pp. 102286-102286
Open Access

Annexin A’s Life in Pan-Cancer: Especially in Glioma Immune Cells
Yongqiang Wen, Wenhao Zhou, Z. Zhao, et al.
NeuroMolecular Medicine (2025) Vol. 27, Iss. 1
Closed Access

Roles of Annexin A1 Expression in Small Cell Lung Cancer
Ágnes Paál, Dávid Dóra, Ákos Takács, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1407-1407
Open Access

Upregulation of RACGAP1 is correlated with poor prognosis and immune infiltration in hepatocellular carcinoma
Yangyang Zhou, Shimeng Zheng, Qihang Guo, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 2, pp. 847-863
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top